Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CardioSAVE: A 12-months Prospective Longitudinal Controlled Study for the Validation of a Novel Predictive Model and a Diagnostic Tool, for the Risk Stratification of AMI Patients Undergoing PCI

NCT03038360 is registered in ClinicalTrials.gov with Firalis SA as lead sponsor.

NCT NCT03038360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CardioSAVE: A 12-months Prospective Longitudinal Controlled Study for the Validation of a Novel Predictive Model and a Diagnostic Tool, for the Risk Stratification of AMI Patients Undergoing PCI
Lead sponsor
Firalis SA
Phase
Observational
Overall status
Completed
Start date
September 10, 2014
Completion date
October 30, 2021
Enrollment
620 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure